Reverse Convertible Bond 5,7% Health Care Aktienanleihe The product related information contained herein is exclusively for information purposes only, intended for current investors or in case these products are displayed further to an individual search. The information does not constitute a recommendation or an offer to buy or an invitation to make a respective offer in relation to any of the products described herein.
Issue price100.00% Redemption price100.00% Issue dateMar 09, 2020 Maturity dateMar 09, 2022
Name
5,7% Health Care Aktienanleihe
ISIN / WKN
AT0000A2CQC4 / RC0WXD
Underlying
Capital protection amount
-
Participation factor
-
Cap
unlimited
Coupon p.a. in %
5.70%
Underlying price
-
Starting value
EUR 100.00
Strike
EUR 100.00
Denomination / nominal
EUR 1,000
Payed Coupons
5.70% on Mar 09, 2021
5.70% on Mar 09, 2022
About the term
Initial valuation date
Mar 06, 2020
Issue date
Mar 09, 2020
Final valuation date
Mar 04, 2022
Maturity date
Mar 09, 2022
Product classification
Investment Product without Capital Protection
Security type (eusipa Nr.)
Reverse Convertible Bond (1230)
Reverse Convertible Bond Type
Barrier Reverse Convertible Bonds
Underlying
Country / region of underlying
-
Suited market expectation
sideways, bullish
Observation barrier
Closing Price
Issue price
100.00%
Spread homogenised
-
Spread in %
-
Multiplier
-
Product currency
EUR
Underlying currency
-
Settlement method
Cash settlement / Physical delivery
Tax treatment
Capital Gains Tax / EU Withholding Tax
Public offer in
Austria, Germany, Italy, Hungary, Poland, Czech Republic, Slovakia, Bulgaria, Croatia, Romania, Slovenia
Listing
Vienna, Frankfurt, Stuttgart
Comments

The 5.7% Health Care Convertible Bond is redeemed at 100% nominal value at the maturity date (March 2022), provided that, during the observation period, the closing price of each of the three underlying shares (Fresenius SE & Co. KGaA, Koninklijke Philips N.V. and Sanofi S.A.) always quoted above the barrier of 59% of the strike (daily observation). The interest amount of 5.7% is paid out annually, regardless of the performance of the underlying shares.In case the barrier is touched or undercut by at least one of the underlying shares and at least one of the underlying shares quotes below its strike at the final valuation date, the predefined amount of the worst performing share will be delivered. If all three underlying shares quote at or above their strike at the final valuation date, the product is redeemed at 100% nominal value despite a barrier event.